Abstract
Electronic Health Record (EHR) audit log data are increasingly utilized for clinical tasks, from workflow modeling to predictive analyses of discharge events, adverse kidney outcomes, and hospital readmissions. These data encapsulate user-EHR interactions, reflecting both healthcare professionals’ behavior and patients’ health statuses. To harness this temporal information effectively, this study explores the application of Large Language Models (LLMs) in leveraging audit log data for clinical prediction tasks, specifically focusing on discharge predictions. Utilizing a year’s worth of EHR data from Vanderbilt University Medical Center, we fine-tuned LLMs with randomly selected 10,000 training examples. Our findings reveal that LLaMA-2 70B, with an AUROC of 0.80 [0.77-0.82], outperforms both GPT-4 128K in a zero-shot, with an AUROC of 0.68 [0.65-0.71], and DeBERTa, with an AUROC of 0.78 [0.75-0.82]. Among various serialization methods, the first-occurrence approach—wherein only the initial appearance of each event in a sequence is retained—shows superior performance. Furthermore, for the fine-tuned LLaMA-2 70B, logit outputs yield a higher AUROC of 0.80 [0.77-0.82] compared to text outputs, with an AUROC of 0.69 [0.67-0.72]. This study underscores the potential of fine-tuned LLMs, particularly when combined with strategic sequence serialization, in advancing clinical prediction tasks.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was supported, in part, by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR002243. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This retrospective study was approved by the institutional review board (IRB) at Vanderbilt University Medical Center (VUMC) under IRB#191892.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
